Stop suffering with constant dry, red, and irritated eyes.
Let TheraLife put you on the right path to dry eye relief.
Tips to relief dry eyes now. Get help with TheraLife
Call and talk to Dr. Yang at 1-877-917-1989 US/Canada, international call (650) 949-6080. Send email to [email protected]
Do you have dry eye syndrome?
Almost everyone has experienced dry eye syndrome at least once. That dry, irritated feeling that lets a person know that the eyes are not moist and properly protected from dirt or bacteria. Usually, the symptoms go away on their own, but when dry eyes persist, this can lead to a life full of constant painful, itchy eyes. Left untreated, not only will symptoms get worse, but vision can be affected.
Causes of Dry Eye Syndrome
There are many varied reasons that dry eyes develop, including:
- Age – As a person ages naturally, those who are over 65 will experience some of the symptoms of dry eyes
- Gender – Due to hormonal changes during pregnancy, menopause, or the use of oral contraceptives, dry eyes can develop in women
- Medication – Particular medications, such as antihistamines, antidepressants, or even blood pressure medications can cause a reduction in tear quality and production
- Medical Conditions – Certain medical problems such as arthritis, diabetes and thyroid issues can ultimately lead to dry eyes
- Environment – Smoke, windy or dry air, or pollutants can increase the amount of evaporation of tears
- Computers – Staring at a computer screen without blinking regularly can lead to dry eyes
- Corrective Measures – LASIK surgery or contact lenses can cause eyes to dry out
- Particular Eye Conditions – Inflammation, blepharitis, or a defect of the eyelids can also lead to dry eyes
Symptoms of Dry Eye Syndrome
How can a person identify and treat chronic dry eye syndrome? The symptoms can affect one or both eyes, and include:
- Scratchy, stinging, or burning sensation in one or both eyes
- Thick, stringy mucus around or in the eyes
- Noticeable sensitivity to light
- Eyes that stay red
- A feeling that something is in one or both eyes
- Contact lenses that are uncomfortable
- Night driving difficulty
- Watery eyes
- Blurred vision
- Tired eyes
If any of these symptoms persist, see a doctor for a determination, and then visit TheraLife for a complete line of products that help relieve and even eliminate these symptoms.
Proper Diagnosis of Dry Eye Syndrome
Through a series of comprehensive eye examinations by a qualified doctor, the quality and quantity of tear production can be determined. Some tests determine health problems, medications, or outside factors that may contribute to dry eyes, whereas other tests look at the external makeup and structures of the eyes.
Tear production and attributes are also tested.
When visiting a doctor, some tests that a patient might experience include:
- Schirmer’s Test – Used to determine tear production, this test is commonly used to determine dry eye syndrome. If the eyes are producing too many or too few tears, this test can help determine the best treatment options.
- Rose Bangel Stains – The damage to epithelial cells can be determined with a stain that is placed on the eye surface. Drops are placed in the eyes and after 3 to 5 minutes, a determination of tear shortage or absence can be made.
- Tear Break-up Test – Measurement of fluorescein break-up time in the tears. This can also be determined using non-invasive measures such as use of a Keratometer, Keratoscope, or Tearscope.
Once a determination has been made to the reason for dry eyes, a proper treatment plan can be put in place. TheraLife has many different products available to treat a wide variety of dry eye symptoms and causes.
Treatment with TheraLife
Although dry eyes can be temporarily treated with over-the-counter artificial tears, those who suffer with dry eye syndrome need long term relief.
TheraLife addresses the many different ways to successfully treat dry eye syndrome with their complete line of products.
As a leader in chronic dry eye relief, TheraLife addresses the source of the problem of dry eyes instead of masking the symptoms. Underactive tear secretion is addressed from the inside out with natural products.
TheraLife provides a complete relief from dry eyes by helping the body produce its own tears, eliminating inflammation and dryness.
Clinically proven to work for 80% of first-time users, the natural TheraLife formula allows for the restoration and revitalization of tear secretion from the glands on a cellular level to allow the eyes to produce tears that are balanced and sustainable.
Frequently Asked Questions
What is the best treatment for very dry eyes?
Best treatment for very dry eye is a combination of TheraLife Eye capsules, Omega 3 fish oil, Warm compresses and Avenova eyelid cleanser. This treatment protocol addresses relieve for chronic dry eyes; lubricating and thicken tears with Omega 3, unclog meibomian oil glands with warm compress and treat blepharitis with AVenova eyelid cleanser.
A protocol that has proven to work clinically.
How can I permanently treat dry eyes at home?
You can treat your dry eyes permanently at home by drinking a lot of water, stop drinking coffee and soda – which has a lot of sugar, exercise, stop smoking, get plenty of sleep and wear wrap around sunglasses outdoors. If you still experience symptoms, take TheraLife Eye capsules and follow the protocol to fast relief. Preserve your eyes for optimum health.
Can dry eyes be cured naturally?
There is no cure for dry eyes naturally. Dry eyes is caused by aging, hormone changes, contact lens wearing, autoimmune diseases and sometimes hereditary. TheraLife Eye capsules are all natural, clinical proven to work, safe and effective. Try TheralIfe today.
What is a good vitamin for dry eyes?
There are good vitamins and supplement for dry eyes. Examples are Omega 3 fish oil, and Vitamin D. Explore 100% pure Omega 3 fish oil from TheraLife. Molecularly distilled for purity and efficacy.
Is dry eye curable?
There is no cure for dry eyes. However we can help you manage symptoms and prevent cornea damage. Putting your life back on track.
Conclusion
The pathogenesis of DED is complex and multifactorial. Currently, inflammation at the ocular surface is the main cause of DED. The corresponding anti-inflammatory pathways are the key targets in DED treatment. studies have confirmed that inflammatory cells and inflammatory factors are closely associated with the tear film instability and the elevated tear osmolarity.
Let TheraLife relief your dry eyes and improve the quality of your life.
References
1. Galor A, Feuer W, Lee DJ, Florez H, Carter D, Pouyeh B, et al. Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population. Am J Ophthalmol. (2011) 152:377–84 e2. doi: 10.1016/j.ajo.2011.02.026. PubMed Abstract | CrossRef Full Text | Google Scholar2.
2. Le Q, Ge L, Li M, Wu L, Xu J, Hong J, et al. Comparison on the vision-related quality of life between outpatients and general population with dry eye syndrome. Acta Ophthalmol. (2014) 92:e124–32. doi: 10.1111/aos.12204 PubMed Abstract | CrossRef Full Text | Google Scholar3.
3. Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS II Epidemiology Report. Ocul Surf. (2017) 15:334–65. doi: 10.1016/j.jtos.2017.05.003PubMed Abstract | CrossRef Full Text | Google Scholar
4. Gomes JAP, Santo RM. The impact of dry eye disease treatment on patient satisfaction and quality of life: A review. Ocul Surf. (2019) 17:9–19. doi: 10.1016/j.jtos.2018.11.003
PubMed Abstract | CrossRef Full Text | Google Scholar
5.Hantera MM. Trends in dry eye disease management worldwide. Clin Ophthalmol. (2021) 15:165–73. doi: 10.2147/OPTH.S281666 PubMed Abstract | CrossRef Full Text | Google Scholar
6. Pflugfelder SC, Stern ME. The cornea in keratoconjunctivitis sicca. Exp Eye Res. (2020) 201:108295. doi: 10.1016/j.exer.2020.108295 PubMed Abstract | CrossRef Full Text | Google Scholar.
7.Mochizuki M, Sugita S, Kamoi K. Immunological homeostasis of the eye. Prog Retin Eye Res. (2013) 33:10–27. doi: 10.1016/j.preteyeres.2012.10.002 PubMed Abstract | CrossRef Full Text | Google Scholar
8. Stern ME, Schaumburg CS, Siemasko KF, Gao J, Wheeler LA, Grupe DA, et al. Autoantibodies contribute to the immunopathogenesis of experimental dry eye disease. Invest Ophthalmol Vis Sci. (2012) 53:2062–75. doi: 10.1167/iovs.11-9299 PubMed Abstract | CrossRef Full Text | Google Scholar
9. Guzman M, Keitelman I, Sabbione F, Trevani AS, Giordano MN, Galletti JG. Mucosal tolerance disruption favors disease progression in an extraorbital lacrimal gland excision model of murine dry eye. Exp Eye Res. (2016) 151:19–22. doi: 10.1016/j.exer.2016.07.004 PubMed Abstract | CrossRef Full Text | Google Scholar
10. Pflugfelder SC, de Paiva CS. The pathophysiology of dry eye disease: what we know and future directions for research. Ophthalmology. (2017) 124:S4–S13. doi: 10.1016/j.ophtha.2017.07.010 PubMed Abstract | CrossRef Full Text | Google Scholar
11. Barbosa FL, Xiao Y, Bian F, Coursey TG, Ko BY, Clevers H, et al. Goblet cells contribute to ocular surface immune tolerance-implications for dry eye disease. Int J Mol Sci. (2017) 18. doi: 10.3390/ijms18050978 PubMed Abstract | CrossRef Full Text | Google Scholar
12. Bertoni A, Alabiso O, Galetto AS, Baldanzi G. Integrins in T cell physiology. Int J Mol Sci. (2018) 19. doi: 10.3390/ijms19020485 PubMed Abstract | CrossRef Full Text | Google Scholar
13. Yamaguchi T. Inflammatory response in dry eye. Invest Ophthalmol Vis Sci. (2018) 59:DES192–DES9. doi: 10.1167/iovs.17-23651 PubMed Abstract | CrossRef Full Text | Google Scholar
14. Zhang X, Volpe EA, Gandhi NB, Schaumburg CS, Siemasko KF, Pangelinan SB, et al. NK cells promote Th-17 mediated corneal barrier disruption in dry eye. PLoS ONE. (2012) 7:e36822. doi: 10.1371/journal.pone.0036822 PubMed Abstract | CrossRef Full Text | Google Scholar
15. Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. (2012) 130:90–100. doi: 10.1001/archophthalmol.2011.364 PubMed Abstract | CrossRef Full Text | Google Scholar
16. Strauss-Albee DM, Horowitz A, Parham P, Blish CA. Coordinated regulation of NK receptor expression in the maturing human immune system. J Immunol. (2014) 193:4871–9. doi: 10.4049/jimmunol.1401821 PubMed Abstract | CrossRef Full Text | Google Scholar
17. Hu D, Tjon EC, Andersson KM, Molica GM, Pham MC, Healy B, et al. Aberrant expression of USF2 in refractory rheumatoid arthritis and its regulation of proinflammatory cytokines in Th17 cells. Proc Natl Acad Sci U S A. (2020) 117:30639–48. doi: 10.1073/pnas.2007935117 PubMed Abstract | CrossRef Full Text | Google Scholar
18. Bian F, Pelegrino FS, Henriksson JT, Pflugfelder SC, Volpe EA, Li DQ, et al. Differential effects of dexamethasone and doxycycline on inflammation and mmp production in murine alkali-burned corneas associated with dry eye. Ocul Surf. (2016) 14:242–54. doi: 10.1016/j.jtos.2015.11.006 PubMed Abstract | CrossRef Full Text | Google Scholar
19. Manoussakis MN, Boiu S, Korkolopoulou P, Kapsogeorgou EK, Kavantzas N, Ziakas P, et al. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjogren’s syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development. Arthritis Rheum. (2007) 56:3977–88. doi: 10.1002/art.23073 PubMed Abstract | CrossRef Full Text | Google Scholar
20. Sisto M, Lisi S, Ingravallo G, Lofrumento DD, D’Amore M, Ribatti D. Neovascularization is prominent in the chronic inflammatory lesions of Sjogren’s syndrome. Int J Exp Pathol. (2014) 95:131–7. doi: 10.1111/iep.12061 PubMed Abstract | CrossRef Full Text | Google Scholar
21. You IC, Coursey TG, Bian F, Barbosa FL, de Paiva CS, Pflugfelder SC. Macrophage Phenotype in the Ocular Surface of Experimental Murine Dry Eye Disease. Arch Immunol Ther Exp (Warsz). (2015) 63:299–304. doi: 10.1007/s00005-015-0335-0 PubMed Abstract | CrossRef Full Text | Google Scholar
22. Chen Y, Chauhan SK, Saban DR, Sadrai Z, Okanobo A, Dana R. Interferon-gamma-secreting NK cells promote induction of dry eye disease. J Leukoc Biol. (2011) 89:965–72. doi: 10.1189/jlb.1110611 PubMed Abstract | CrossRef Full Text | Google Scholar
23. De Paiva CS, Raince JK, McClellan AJ, Shanmugam KP, Pangelinan SB, Volpe EA, et al. Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13. Mucosal Immunol. (2011) 4:397–408. doi: 10.1038/mi.2010.82 PubMed Abstract | CrossRef Full Text | Google Scholar
24. Lee MH, Choi JW, Jang WR, Kim JM, Kim JH. Activation of eosinophils is more closely linked with interleukin-5 and nitric oxide production than tumor necrosis factor-alpha and immunoglobulin E levels. Acta Haematol. (2013) 130:238–41. doi: 10.1159/000350474 PubMed Abstract | CrossRef Full Text | Google Scholar
25. Galletti JG, Guzman M, Giordano MN. Mucosal immune tolerance at the ocular surface in health and disease. Immunology. (2017) 150:397–407. doi: 10.1111/imm.12716 PubMed Abstract | CrossRef Full Text | Google Scholar
26. Alam J, de Paiva CS, Pflugfelder SC. Desiccation induced conjunctival monocyte recruitment and activation – implications for keratoconjunctivitis. Front Immunol. (2021) 12:701415. doi: 10.3389/fimmu.2021.701415 PubMed Abstract | CrossRef Full Text | Google Scholar
27. Yoon KC, Park CS, You IC, Choi HJ, Lee KH, Im SK, et al. Expression of CXCL9,−10,−11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. Invest Ophthalmol Vis Sci. (2010) 51:643–50. doi: 10.1167/iovs.09-3425 PubMed Abstract | CrossRef Full Text | Google Scholar
28. Pflugfelder SC. Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture. Am J Ophthalmol. (2011) 152:900–9 e1. doi: 10.1016/j.ajo.2011.08.023 PubMed Abstract | CrossRef Full Text | Google Scholar
29. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol. (2007) 8:345–50. doi: 10.1038/ni0407-345 PubMed Abstract | CrossRef Full Text | Google Scholar
30. De Paiva CS, Chotikavanich S, Pangelinan SB, Pitcher JD. 3rd, Fang B, Zheng X, et al. IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol. (2009) 2:243–53. doi: 10.1038/mi.2009.5 PubMed Abstract | CrossRef Full Text | Google Scholar
I have dry eye. But this time of year, allergies are also a problem. Are these drops over the counter?
Rexann
TheraLife is not an eye drop. You can purchase directly from us. We are located in California. Tell me more about your dry eyes, perhaps I can help point you to the best protocol to recovery faster. Call me toll free 1-877-917-1989. Dr5. Yang, TheraLife Incn.